These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 18321200

  • 1. Mycophenolate mofetil in the treatment of ocular inflammation in ANCA-associated vasculitis.
    Yalçindağ FN, Amer R, Forrester JV.
    J Ocul Pharmacol Ther; 2008 Apr; 24(2):249-54. PubMed ID: 18321200
    [Abstract] [Full Text] [Related]

  • 2. Tolerance of mycophenolate mofetil in end-stage renal disease patients with ANCA-associated vasculitis.
    Haubitz M, de Groot K.
    Clin Nephrol; 2002 Jun; 57(6):421-4. PubMed ID: 12078944
    [Abstract] [Full Text] [Related]

  • 3. Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement.
    Hu W, Liu C, Xie H, Chen H, Liu Z, Li L.
    Nephrol Dial Transplant; 2008 Apr; 23(4):1307-12. PubMed ID: 18065810
    [Abstract] [Full Text] [Related]

  • 4. Mycophenolate mofetil therapy for sarcoidosis-associated uveitis.
    Bhat P, Cervantes-Castañeda RA, Doctor PP, Anzaar F, Foster CS.
    Ocul Immunol Inflamm; 2009 Apr; 17(3):185-90. PubMed ID: 19585361
    [Abstract] [Full Text] [Related]

  • 5. Treatment of acute c-ANCA-positive vasculitis with mycophenolate mofetil.
    Waiser J, Budde K, Braasch E, Neumayer HH.
    Am J Kidney Dis; 1999 Sep; 34(3):e9. PubMed ID: 10471756
    [Abstract] [Full Text] [Related]

  • 6. Mycophenolate mofetil in anti-neutrophil cytoplasm antibodies-associated systemic vasculitis.
    Koukoulaki M, Jayne DR.
    Nephron Clin Pract; 2006 Sep; 102(3-4):c100-7. PubMed ID: 16286784
    [Abstract] [Full Text] [Related]

  • 7. Mycophenolate mofetil in the treatment of uveitis in children.
    Doycheva D, Deuter C, Stuebiger N, Biester S, Zierhut M.
    Br J Ophthalmol; 2007 Feb; 91(2):180-4. PubMed ID: 16825275
    [Abstract] [Full Text] [Related]

  • 8. Mycophenolate mofetil for ocular inflammation.
    Daniel E, Thorne JE, Newcomb CW, Pujari SS, Kaçmaz RO, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Foster CS, Jabs DA, Kempen JH.
    Am J Ophthalmol; 2010 Mar; 149(3):423-32.e1-2. PubMed ID: 20042178
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A pilot study using mycophenolate mofetil in relapsing or resistant ANCA small vessel vasculitis.
    Joy MS, Hogan SL, Jennette JC, Falk RJ, Nachman PH.
    Nephrol Dial Transplant; 2005 Dec; 20(12):2725-32. PubMed ID: 16188901
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Induction of remission in active anti-neutrophil cytoplasmic antibody-associated vasculitis with mycophenolate mofetil in patients who cannot be treated with cyclophosphamide.
    Stassen PM, Tervaert JW, Stegeman CA.
    Ann Rheum Dis; 2007 Jun; 66(6):798-802. PubMed ID: 17179175
    [Abstract] [Full Text] [Related]

  • 13. Mycophenolate mofetil therapy for inflammatory eye disease.
    Thorne JE, Jabs DA, Qazi FA, Nguyen QD, Kempen JH, Dunn JP.
    Ophthalmology; 2005 Aug; 112(8):1472-7. PubMed ID: 16061096
    [Abstract] [Full Text] [Related]

  • 14. Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis.
    Chan TM, Tse KC, Tang CS, Mok MY, Li FK, Hong Kong Nephrology Study Group.
    J Am Soc Nephrol; 2005 Apr; 16(4):1076-84. PubMed ID: 15728784
    [Abstract] [Full Text] [Related]

  • 15. Infliximab improves endothelial dysfunction in systemic vasculitis: a model of vascular inflammation.
    Booth AD, Jayne DR, Kharbanda RK, McEniery CM, Mackenzie IS, Brown J, Wilkinson IB.
    Circulation; 2004 Apr 13; 109(14):1718-23. PubMed ID: 15037536
    [Abstract] [Full Text] [Related]

  • 16. Mycophenolate mofetil as maintenance therapy in patients with vasculitis and renal involvement.
    Iatrou C, Zerbala S, Revela I, Spanou E, Marinaki S, Nakopoulou L, Boletis J.
    Clin Nephrol; 2009 Jul 13; 72(1):31-7. PubMed ID: 19640385
    [Abstract] [Full Text] [Related]

  • 17. Mycophenolate mofetil in low doses stabilizes and improves antineutrophil cytoplasmic antibody-associated vasculitis and lupus nephritis.
    Kazderova M, Jancova E, Rysava R, Merta M, Tesar V.
    Arch Med Res; 2008 Jan 13; 39(1):115-9. PubMed ID: 18068004
    [Abstract] [Full Text] [Related]

  • 18. Long-term efficacy of mycophenolate mofetil in the control of severe intraocular inflammation.
    Lau CH, Comer M, Lightman S.
    Clin Exp Ophthalmol; 2003 Dec 13; 31(6):487-91. PubMed ID: 14641155
    [Abstract] [Full Text] [Related]

  • 19. Mycophenolate mofetil for the treatment of scleritis.
    Sen HN, Suhler EB, Al-Khatib SQ, Djalilian AR, Nussenblatt RB, Buggage RR.
    Ophthalmology; 2003 Sep 13; 110(9):1750-5. PubMed ID: 13129873
    [Abstract] [Full Text] [Related]

  • 20. Mycophenolate mofetil after methotrexate failure or intolerance in the treatment of scleritis and uveitis.
    Sobrin L, Christen W, Foster CS.
    Ophthalmology; 2008 Aug 13; 115(8):1416-21, 1421.e1. PubMed ID: 18221998
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.